Affimed GmbH
Industry / private company
Location:
Heidelberg,
Germany (DE)
NK cell-mediated tumor cell killing by bispecific innate cell engagers induces ADCC-mediated activation of primary human dendritic cells (2026)
Heger L, Kaszubowski T, Amon L, Lehmann C, Wingert S, Medina-Echeverz J, Koch J, et al.
Journal article
Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11 (2019)
Duell J, Lukic DS, Karg M, Reusch U, Koch J, Zhukovsky EA, Rajkovic E, et al.
Journal article